Elanco makes offer on Janssen Animal Health
Indianapolis - Elano, the animal-health division of Eli Lilly and Co., has made an upspecified offer to acquire the animal-health portfolio owned by Janssen Pharmaceutica, a Johnson & Johnson company.
INDIANAPOLIS — Elanco, the animal-health division of Eli Lilly and Co., has made an unspecified offer to acquire the animal-health portfolio owned by Janssen Pharmaceutica, a Johnson & Johnson company.
The deal would give Elanco approximately 50 new animal-health products and move Janssen employees to Elanco. No manufacturing facilities would be affected by the acquisition, Elanco officials report.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Recent Videos
Related Content
